Recent Finacing
Recent Raise
ImMAGE Biotherapeutics develops protein-targeted therapeutics for triple-negative breast cancer, operating from Washington, DC/Bethesda and advancing an eight-candidate pipeline toward preclinical animal studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor